Home » Stocks » MBOT

Microbot Medical Inc. (MBOT)

Stock Price: $7.31 USD -0.13 (-1.75%)
Updated November 23, 4:00 PM EST - Market closed
After-hours: $7.40 +0.09 (1.23%) Nov 23, 7:25 PM

Stock Price Chart

Key Info

Market Cap 51.96M
Revenue (ttm) n/a
Net Income (ttm) -8.40M
Shares Out 7.11M
EPS (ttm) -1.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $7.31
Previous Close $7.44
Change ($) -0.13
Change (%) -1.75%
Day's Open 7.45
Day's Range 7.24 - 7.68
Day's Volume 244,221
52-Week Range 4.30 - 20.15

More Stats

Market Cap 51.96M
Enterprise Value 26.16M
Earnings Date (est) Apr 5, 2021
Ex-Dividend Date n/a
Shares Outstanding 7.11M
Float 6.71M
EPS (basic) -1.35
EPS (diluted) -1.31
FCF / Share -1.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 443,856
Short Ratio 3.14
Short % of Float 6.62%
Beta 5.14
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 2.02
Revenue n/a
Operating Income -8.45M
Net Income -8.40M
Free Cash Flow -7.54M
Net Cash 25.80M
Net Cash / Share 3.63
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -26.98%
ROE -51.11%
ROIC -719.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$20.00*
Low
20.0
Current: $7.31
High
20.0
Target: 20.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue-----1.010.170.491.221.43
Revenue Growth-----487.58%-64.82%-59.88%-14.46%-
Gross Profit-----1.010.170.491.011.26
Operating Income-7.24-7.24-5.27-9.64-0.92-30.91-28.09-21.91-28.08-29.36
Net Income-7.25-7.26-7.59-9.66-0.92-32.74-26.44-28.49-21.33-25.24
Shares Outstanding4.272.902.180.950.060.040.030.020.010.01
Earnings Per Share-1.70-2.41-2.76-6.00-0.60-858.60-988.20-1,603.80-2,430.00-3,321.00
Operating Cash Flow-6.45-5.31-4.86-0.79-0.77-27.35-23.32-19.87-22.06-24.52
Capital Expenditures0.04-0.22-0.06-0.03--0.90-4.64-0.07-0.30-0.92
Free Cash Flow-6.41-5.53-4.91-0.81-0.77-28.25-27.96-19.94-22.36-25.44
Cash & Equivalents35.655.2610.812.710.4424.9930.5922.3716.5919.90
Total Debt0.90--0.080.4215.0513.080.350.540.78
Net Cash / Debt34.755.2610.812.630.029.9417.5022.0216.0519.11
Assets37.136.0911.023.370.5332.4341.5630.1725.2130.60
Liabilities5.594.760.561.170.5926.5626.6016.1914.4815.12
Book Value31.541.339.961.70-0.065.8714.9513.9810.7315.48
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Microbot Medical Inc.
Country United States
Employees 10
CEO Harel Gadot

Stock Information

Ticker Symbol MBOT
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: MBOT

Description

Microbot Medical, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.